Trademark: 86022872
Word
LIFAZRA
Status
Dead
Status Code
606
Status Date
Monday, January 12, 2015
Serial Number
86022872
Mark Type
4000
Filing Date
Monday, July 29, 2013
Published for Opposition
Tuesday, April 15, 2014
Abandoned Date
Monday, January 12, 2015
Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication
Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Trademark Events
Jan 12, 2015
Abandonment Notice Mailed - No Use Statement Filed
Jan 12, 2015
Abandonment - No Use Statement Filed
Jun 10, 2014
Noa E-Mailed - Sou Required From Applicant
Apr 15, 2014
Official Gazette Publication Confirmation E-Mailed
Apr 15, 2014
Published For Opposition
Mar 26, 2014
Notification Of Notice Of Publication E-Mailed
Mar 11, 2014
Law Office Publication Review Completed
Mar 10, 2014
Assigned To Lie
Feb 21, 2014
Approved For Pub - Principal Register
Feb 21, 2014
Teas/Email Correspondence Entered
Feb 21, 2014
Correspondence Received In Law Office
Feb 21, 2014
Teas Response To Office Action Received
Nov 12, 2013
Notification Of Non-Final Action E-Mailed
Nov 12, 2013
Non-Final Action E-Mailed
Nov 12, 2013
Non-Final Action Written
Nov 12, 2013
Assigned To Examiner
Aug 3, 2013
New Application Office Supplied Data Entered In Tram
Aug 1, 2013
New Application Entered In Tram
LARECLYN
JASSI
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov